Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1980 Aug;69(4):551–554. doi: 10.1111/j.1476-5381.1980.tb07902.x

Biological effects of degradation products of collagen by bacterial collagenase.

W Buczko, J Dziaczkowski, M Kopec, J Moniuszko-Jakoniuk, I Sopata, K Wisniewski, J Wize, E Wojtecka-Lukasik
PMCID: PMC2044296  PMID: 6254591

Abstract

1 Collagen degradation products (CDP) resulting from bacterial collagenase digestion were fractionated by gel filtration and their biological activities in rats were estimated. 2 CDP induced the following kinin-like effects: increase in permeability of skin blood vessels, contraction of the isolated intestine of the rat, depression of locomotor activity and of motor coordination. 3 The most active CDP fraction was CDP III containing peptides of mol. wt. < 1000 D with a high percentage of hydroxyproline. 4 As compared with bradykinin, CDP III was less active in the skin permeability test and was 15,000 to 20,000 fold less effective in induction of isolated intestine contraction. 5 Depression of the CNS induced by 30 microgram of CDP III administered into the brain ventricle was similar to that observed after 4 microgram of bradykinin given by the same route. 6 CDP III prolonged the duration of sleep evoked by thiopentone and enhanced the threshold of convulsion induced by pentazol. 7 The activity of CDP in comparison to other low molecular weight peptides is discussed.

Full text

PDF
551

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Buczko W. Effect of fibrinogen degradation products on the rat blood vessels. Acta Physiol Pol. 1977 Mar-Apr;28(2):153–159. [PubMed] [Google Scholar]
  2. Buczko W., Franco R., Bianchetti G., Donati M. B., de Gaetano G., Garattini S. Positive chronotropic effect of dialysable peptides derived from plasmin digestion of bovine fibrinogen preparations. Eur J Pharmacol. 1976 Apr;36(2):355–361. doi: 10.1016/0014-2999(76)90089-3. [DOI] [PubMed] [Google Scholar]
  3. Buczko W., Moniuszko-Jakoniuk J. Influence of fibrinogen degradation products (FDP) on the central nervous system and on the effects of centrally acting drugs. Pharmacology. 1975;13(3):252–259. doi: 10.1159/000136912. [DOI] [PubMed] [Google Scholar]
  4. Buluk K., Malofiejew M. The pharmacological properties of fibrinogen degradation products. Br J Pharmacol. 1969 Jan;35(1):79–89. doi: 10.1111/j.1476-5381.1969.tb07968.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Christensen J. D. The rotacone: a new apparatus for measuring motor coordination in mice. Acta Pharmacol Toxicol (Copenh) 1973;33(4):255–261. doi: 10.1111/j.1600-0773.1973.tb01525.x. [DOI] [PubMed] [Google Scholar]
  6. Harris E. D., Jr, Krane S. M. Collagenases (first of three parts). N Engl J Med. 1974 Sep 12;291(11):557–563. doi: 10.1056/NEJM197409122911105. [DOI] [PubMed] [Google Scholar]
  7. Herman Z. S. The effects of noradrenaline on rat's behaviour. Psychopharmacologia. 1970;16(5):369–374. doi: 10.1007/BF00404847. [DOI] [PubMed] [Google Scholar]
  8. Hori S., Masumura S., Mizuta K., Kondo M. Kallikreins and their inhibitors in various tissues. Mie Med J. 1969 Jan;18(3):223–233. [PubMed] [Google Scholar]
  9. Kang A. H., Bornstein P., Piez K. A. The amino acid sequence of peptides from the cross-linking region of rat skin collagen. Biochemistry. 1967 Mar;6(3):788–795. doi: 10.1021/bi00855a019. [DOI] [PubMed] [Google Scholar]
  10. Kang A. H., Nagai Y., Piez K. A., Gross J. Studies on the structure of collagen utilizing a collagenolytic enzyme from tadpole. Biochemistry. 1966 Feb;5(2):509–515. doi: 10.1021/bi00866a016. [DOI] [PubMed] [Google Scholar]
  11. Stegemann H., Stalder K. Determination of hydroxyproline. Clin Chim Acta. 1967 Nov;18(2):267–273. doi: 10.1016/0009-8981(67)90167-2. [DOI] [PubMed] [Google Scholar]
  12. Tarasiewicz S., Maćkowiak J., Moniuszko-Jakoniuk J., Michalak S. Influence of globulin degradation products (GDP) on some centrally acting drugs. Acta Med Pol. 1977;18(2):113–121. [PubMed] [Google Scholar]
  13. Udaka K., Takeuchi Y., Movat H. Z. Simple method for quantitation of enhanced vascular permeability. Proc Soc Exp Biol Med. 1970 Apr;133(4):1384–1387. doi: 10.3181/00379727-133-34695. [DOI] [PubMed] [Google Scholar]
  14. Wisniewski K., Tarasiewicz S., Maćkowiak J., Buczko W., Moniuszko-Jakoniuk J. The effects of trypsin digested globulin degradation products (TDPG) on the activity of central nervous system. Pharmacology. 1974;12(6):321–330. doi: 10.1159/000136555. [DOI] [PubMed] [Google Scholar]
  15. Wiśniewski K., Buczko W., Moniuszko-Jakoniuk J. The effect of products of fibrinogen digestion by plasmin (P-FDP) on the central nervous system. Acta Neurobiol Exp (Wars) 1975;35(3):275–283. [PubMed] [Google Scholar]
  16. Zwoliński J., Buczko W. Influence of fibrinogen degradation products on the action of amphetamine in the central nervous system. Pol J Pharmacol Pharm. 1977 May-Jun;29(3):313–319. [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES